Lung Health Study (LHS) I and III
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00000568|
Recruitment Status : Completed
First Posted : October 28, 1999
Last Update Posted : April 14, 2016
In the Lung Health Study I, to determine the effects of Special Care, compared to Usual Care, on rate of decline in pulmonary function in a group of cigarette smokers identified as having mild abnormalities in pulmonary function.
In the Lung Health Study III, to determine the long-term effects of smoking cessation and continued smoking, on cardiopulmonary morbidity, mortality, and the rate of decline in the one second forced expiratory volume (FEV1) in men and women with early chronic obstructive lung disease who have been followed prospectively for 12 to 15 years.
|Condition or disease||Intervention/treatment||Phase|
|Lung Diseases Lung Diseases, Obstructive Chronic Obstructive Pulmonary Disease||Behavioral: smoking cessation Drug: ipratropium||Phase 3|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Study Start Date :||September 1984|
|Study Completion Date :||January 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000568
|OverallOfficial:||John Connett||University of Minnesota - Clinical and Translational Science Institute|